Rejuvenating Eye Cream
Counter the appearance of puffiness, sagging skin and dark circles in the delicate eye area with remarkable results. Clinically proven ingredients Glissandrin,™ Eyeliss™ and Haloxyl™ smooth the eye contour for more youthful, radiant skin.
This moisturizing eye treatment makes the delicate skin around the eye appear tightened, brightened and toned.
- Eye contours look lifted
- Puffiness and dark circles under the eyes appear reduced
- Skin looks more radiant
Key active ingredients:
- Glissandrin,™ a suite of natural compounds including (-) Schisandrin B, Schisandrin B: The first and only natural compound reported to simultaneously support the natural ability of skin cells to counteract the fundamental cause of skin aging, mitochondrial decay, and help sustain natural cellular anti-oxidant capability.
- Eyeliss™*: Rapidly addresses puffiness under the eyes.
- Haloxyl™*: Reduces the appearance of dark circles under the eyes.
- (N-Hydroxysuccinimide, Chrysin, Hesperidin Methyl Chalcone, Dipeptide and Lipopeptide)*
- Purified Water, Caprylic/Capric Triglyceride, Glissandrin™ Gel *U/C, Glycerin, Cyclomethicone, Acrylates/Acrylamide Copolymer, Aloe Barbadensis Leaf Juice, Dimethicone, PEG-6 Stearate, Beeswax (Cera Alba), Tocopherol, Propylene Glycol, Polysorbate 20, Ceteth-20, Steareth-20, Diazolidinyl Urea, Hesperidin Methyl Chalcone, Parfum (Fragrance), Glyceryl Stearate, Hydroxysuccinimide, Sodium Hyaluronate, Methylparaben, Palmitoyl Tetrapeptide-7, Essential Oils, Dipeptide-2, Chyrsin, Palmitoyl Oligopeptide, Propylparaben
*Matrixyl 3000,™ Eyeliss™ and Haloxyl™ are trademarks of Sederma Inc.; Information supplied by Sederma Inc.
Try Glissandra™ risk-free for 30 days! Our goal is 100% customer satisfaction. If you’re not satisfied with any of our products, simply return them with an explanation and we’ll refund your purchase. You will be reimbursed the amount you paid – excluding shipping and handling and any product discounts.
U.S. Patents #7,396,544 and #7,531,195. Other U.S. and foreign patents pending.